Product Images Pioglitazone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Pioglitazone NDC 68788-7514 by Preferred Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1. Mean Change from Baseline for HbA1c in a 26-Week Placebo-Controlled Dose-Ranging Study (Observed Values) - pioglitazone fig1

Figure 1. Mean Change from Baseline for HbA1c in a 26-Week Placebo-Controlled Dose-Ranging Study (Observed Values) - pioglitazone fig1

The text describes a figure in a 26-week study that shows the mean change from baseline for HbAlc in a dose-ranging experiment. The experiment was placebo-controlled and the figure shows the observed values. The X-axis shows the duration of the study in weeks, while the Y-axis shows the mean change from baseline for HbAlc. The figure displays three dosage levels (15mg, 30mg, 45mg) and illustrates how the HbAlc changes from baseline.*

Pioglitazone Tablets 30mg - pioglitazone fig3

Pioglitazone Tablets 30mg - pioglitazone fig3

chemical structure - pioglitazone str

chemical structure - pioglitazone str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.